Shared Alterations in Gene Expression Networks Mirror Genetic Risk Across Neuropsychiatric Disorders

In comparing gene expression profiles and SNP risk across psychiatric disorders, Michael Gandal, Daniel Geschwind and colleagues found that shared genetic risk manifests in alterations in gene networks.

Featuring

Advances in large-scale genetics efforts have led to the identification of hundreds of genetic risk factors for a variety of psychiatric diseases. Yet how these risk factors function in distinct disorders remains unclear. To address this issue, SFARI Bridge to Independence finalist Michael Gandal, SFARI Investigator Daniel Geschwind and colleagues examined quantitative brain transcriptome profiles for five major psychiatric diseases: autism, schizophrenia, bipolar disorder, depression and alcoholism. Comparison between these profiles uncovered alterations in a variety of shared and distinct gene expression networks. By comparing these profiles to single-nucleotide polymorphism (SNP) risk factors for each disorder, the authors also demonstrated that overlapping alterations in gene-expression profiles mirror the overlap in risk SNPs between disorders. These data argue that these risk SNPs play a causal role in regulating the identified gene pathways and suggest underlying mechanisms by which these risk variants lead to shared behavioral and clinical presentations.

Network diagram showing clusters of gene interactions labeled as neuron, endothelial, astrocyte, and microglia, with connecting green lines and identified groups CD1, CD2, CD4, CD5, CD11, and CD12.
Gene expression modules. Gene expression was assessed across several modules, including neuron, astrocyte and microglia modules. For the modules most disrupted, the top 20 hub genes and their networks are shown. Autism, schizophrenia and bipolar disorder shared upregulation of an astrocyte module (CD4) and downregulation of neuronal/microglia modules (CD1, CD10, CD13). Autism was specifically characterized by upregulation of a module (CD11) enriched for microglia markers.